Ertahil-Sit 15/100Mg Tablet

Ertahil-Sit 15/100mg Tablet is a combination medication containing two active ingredients, Ertugliflozin & Sitagliptin. It is used in the management of type 2 diabetes mellitus to help control blood sugar levels.

Features:

• Dual Action: Ertugliflozin works by inhibiting glucose reabsorption in the kidneys, leading to increased glucose excretion in the urine, while Sitagliptin enhances insulin release and inhibits glucagon secretion to reduce blood sugar levels.
• Comprehensive Control: The combination of Ertugliflozin and Sitagliptin offers complementary mechanisms of action, providing more comprehensive blood sugar control compared to either medication alone.
• Convenient Dosage: Ertahil-Sit 15/100mg Tablet combines two diabetes medications into a single tablet, simplifying treatment regimens and improving patient adherence.

Uses:

• Type 2 Diabetes Mellitus: Ertahil-Sit 15/100mg Tablet is indicated for the management of type 2 diabetes mellitus in adults, particularly when blood sugar levels are inadequately controlled with diet and exercise alone or in combination with other antidiabetic medications.

Directions for Use:

• Take Ertahil-Sit 15/100mg Tablet orally with or without food, as directed by your healthcare provider.
• The usual dosage is one tablet once daily.
• Follow the dosage instructions provided by your doctor, and do not exceed the recommended dose.

Precautions:

• Inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking before starting Ertahil-Sit 15/100mg Tablet.
• Monitor blood sugar levels regularly as directed by your doctor while using this medication.
• Report any symptoms of hypoglycemia (low blood sugar) or urinary tract infections to your healthcare provider promptly.
• Use caution if you have a history of kidney problems, as Ertugliflozin may increase the risk of dehydration and kidney-related adverse effects.